Behavioral effects of opioid receptor antagonists in psychopathologic states.
D000341:Affective Disorders, Psychotic / Q000188:drug therapy / Q000503:physiopathology*; D000818:Animals; D001714:Bipolar Disorder / Q000139:chemically induced; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004723:Endorphins / Q000097:blood / Q000502:physiology*; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008774:Methylphenidate / Q000037:antagonists & inhibitors; D008960:Models, Psychological; D009270:Naloxone / Q000627:therapeutic use; D011388:Prolactin / Q000097:blood; D012559:Schizophrenia / Q000188:drug therapy / Q000503:physiopathology*; D001615:beta-Endorphin
D004723:Endorphins; D008774:Methylphenidate; D009270:Naloxone; D001615:beta-Endorphin; D011388:Prolactin; D013006:Growth Hormone; D006854:Hydrocortisone